AIMS: Abnormal Involuntary Movement Scale

What this assessment is

The Abnormal Involuntary Movement Scale, or AIMS, is a 12-item clinician-rated examination for involuntary movements.

It is used most often to detect and monitor possible tardive dyskinesia in people taking medicines that can cause movement disorders.

Seven ratings describe movement in different body regions and combine to form the movement-severity total, which ranges from 0 to 28.

That is the total.

The remaining ratings describe overall severity, functional effect, awareness, and dental factors, but none of them belongs in the movement total.

The pattern matters as much as the sum.

AIMS does not diagnose tardive dyskinesia. It records what the clinician observes at one examination.

Who it was designed for

AIMS appeared in the 1976 ECDEU Assessment Manual for Psychopharmacology. It was designed for trained clinicians monitoring abnormal movements during psychiatric treatment.

The scale is used mainly with adults and sometimes with younger people, but age never removes the need for a full clinical assessment.

Age decides nothing alone.

Medication exposure is important context. So are neurological illness, dental problems, pain, anxiety, and other medicines.

Record the context.

An involuntary movement can have several causes, and an AIMS result cannot decide which explanation fits the person in front of the clinician.

Cause needs assessment.

The examination is especially useful before treatment starts and during follow-up because a baseline helps distinguish a new movement from an existing one.

Do not use AIMS as a patient self-report questionnaire. Observation and clinical judgment are central to the rating.

How it is administered

A clinician observes the person at rest and during a standard sequence of simple movements. The examination usually takes about 10 minutes.

The rater reviews movements involving the face, mouth, limbs, and trunk, then considers the person's awareness and any effect on daily function.

Observation leads.

Standard conditions matter.

Before the examination, record:

• current medicines and recent dose changes
• the date and time of the assessment
• whether movements change with stress or activity
• dental appliances or oral problems
• any neurological or medical condition that can affect movement

Use the standard examination sequence and rating criteria. A casual observation in a waiting room is not a complete AIMS examination.

Repeat assessments should use a similar setting and method when possible. A different rater or incomplete examination can create an apparent change.

What it measures

AIMS measures the location and observed severity of involuntary movement. It also records global clinical judgments and factors that can affect interpretation.

The seven movement ratings cover several body regions. This makes the profile clinically useful even when two people have the same total.

One person may have a marked movement in one region. Another may have mild movements across several regions. Their sums can be similar, but the clinical pictures differ.

Location matters.

The overall ratings add information about severity, incapacitation, and awareness. Dental status matters because oral conditions can alter facial or mouth movements.

AIMS does not measure psychosis, mood, or treatment benefit. A symptom measure such as the PANSS answers a different question.

Keep movement findings separate from psychiatric symptom scores.

How scoring works

Each of the first ten ratings uses a 0-to-4 scale. Zero indicates no observed problem on that rating. Higher values indicate greater severity.

A common research total adds the first seven movement ratings. The range is 0 to 28.

Do not add ratings 8 through 12 to that total.

Ratings 8 through 10 provide separate global information. Ratings 11 and 12 record dental status rather than movement severity.

Some clinical services also use a pattern rule to identify a possible positive examination. That rule looks for a moderate rating in two regions or a more marked rating in one region.

That is not the same as a total-score cutoff.

The New Hampshire clinical form explicitly warns against using a sum to make that classification. Modern trials often use the 0-to-28 movement total to measure change.

State which method you used.

How to interpret an AIMS score

Interpret the seven-region total as a summary of observed movement severity. Higher values indicate more or stronger movements across the rated regions.

There are no universal mild, moderate, and severe total-score bands.

Do not create them.

Review the individual region ratings, global judgments, and examination conditions with the total. A small change spread across several regions can mean something different from a large change in one region.

A clinical trial analysis used the items 1-to-7 total and found that a two-to-three point decrease could represent a meaningful average change in trial populations. That estimate is not a rule for every person or setting.

Repeat scores are most useful when the same version, trained method, and clinical context are used.

Movement can change with posture, attention, anxiety, fatigue, medicine timing, and the amount of time the clinician spends observing each region.

Variation is expected.

If a new or worsening movement appears, the clinician should assess it directly. The total should not delay evaluation.

What the score cannot tell you

AIMS cannot diagnose tardive dyskinesia or identify its cause.

It cannot distinguish a medicine-related movement from Parkinsonism, tremor, akathisia, tics, dental effects, anxiety, or another neurological condition by itself.

A low total does not rule out a clinically important movement in one region. A high total does not prove that one medicine caused the finding.

The score also cannot show how a movement affects the person's priorities unless the clinician asks and records that information.

Do not change or stop medication from an AIMS number alone.

Use medication history, neurological examination, timing, functional effect, and follow-up findings.

The score is evidence, not a diagnosis.

Evidence and limitations

AIMS is brief, structured, and familiar across psychiatric care and clinical research. It can improve detection when clinicians use it regularly rather than relying on unstructured observation.

Its main limitation is rater dependence. Training, observation conditions, and interpretation of the anchors can affect the result.

Movement severity can also vary during the day and with stress, attention, posture, or activity. One examination may not represent the person's usual state.

The 0-to-28 total is useful for tracking, but it removes location detail. The separate region ratings remain clinically important.

Report the date, rater, examination conditions, region profile, movement total, and any global ratings used.

A value stored without its body-region ratings can hide the movement that matters most to the person and the clinician.

Keep the full profile with the number.